Exelixis, Inc.

Exelixis, Inc.verified

EXEL

Price:

$21.74

Market Cap:

$6.33B

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and...[Read more]

Industry

Biotechnology

IPO Date

2000-04-17

Stock Exchange

NASDAQ

Ticker

EXEL

The Dividend Yield as of June 2024 (TTM) for Exelixis, Inc. (EXEL) is 0%

According to Exelixis, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Exelixis, Inc. (EXEL) Historical Dividend Yield (quarterly & annually)

How has EXEL Dividend Yield performed in the past?

The mean historical Dividend Yield of Exelixis, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), EXEL's Dividend Yield was at its highest in in the June 2014 quarter at 0%. The Dividend Yield was at its lowest in in the June 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Exelixis, Inc. (EXEL) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Exelixis, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20210%0%
20200%0%
20180%0%
20170%0%
20160%0%
20160%0%
20140%0%

Exelixis, Inc. (EXEL) Average Dividend Yield

How has EXEL Dividend Yield performed in the past?

The current Dividend Yield of Exelixis, Inc. (EXEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Exelixis, Inc. (EXEL) Dividend Yield vs. Peers

How is EXEL’s Dividend Yield compared to its peers?

Exelixis, Inc.’s Dividend Yield is less than TG Therapeutics, Inc. (0%), less than Viking Therapeutics, Inc. (0%), less than Madrigal Pharmaceuticals, Inc. (0%), less than BioXcel Therapeutics, Inc. (0%), less than BioMarin Pharmaceutical Inc. (0%), less than Seagen Inc. (0%), less than Alnylam Pharmaceuticals, Inc. (0%), less than Halozyme Therapeutics, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than PDS Biotechnology Corporation (0%), less than PTC Therapeutics, Inc. (0%), less than Reata Pharmaceuticals, Inc. (0%), less than Intercept Pharmaceuticals, Inc. (0%), less than Krystal Biotech, Inc. (0%), less than Kodiak Sciences Inc. (0%), less than Sarepta Therapeutics, Inc. (0%), less than Mirati Therapeutics, Inc. (0%),

Build a custom stock screener for Exelixis, Inc. (EXEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exelixis, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exelixis, Inc. (EXEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exelixis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Exelixis, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Exelixis, Inc. (EXEL)?

What is the highest Dividend Yield for Exelixis, Inc. (EXEL)?

What is the 3-year average Dividend Yield for Exelixis, Inc. (EXEL)?

What is the 5-year average Dividend Yield for Exelixis, Inc. (EXEL)?

How does the current Dividend Yield for Exelixis, Inc. (EXEL) compare to its historical average?